• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种具有因子V抑制活性的单克隆IgG4(λ)

A monoclonal IgG4 (lambda) with factor V inhibitory activity.

作者信息

Hurtubise P E, Coots M C, Jacob D J, Muhleman A F, Glueck H I

出版信息

J Immunol. 1979 May;122(5):2119-21.

PMID:109525
Abstract

A monoclonal IgG4 (lambda) with inhibitory activity to human coagulation factor V was isolated from the serum of a patient with a fatal hemorrhagic diathesis by using a combination of DE-52 ion exchange chromatography and isoelectric focusing techniques. Using the criteria for defining a monoclonal immunoglobulin of restricted mobility on protein electrophoresis, immunoelectrophoresis, and isoelectric focusing, as well as neutralization with class, subclass, and light chain type antisera, we are the first to demonstrate a factor V inhibitor as a monoclonal IgG4 (lambda) detectable in serum or plasma.

摘要

通过结合DE-52离子交换色谱法和等电聚焦技术,从一名患有致命性出血素质的患者血清中分离出一种对人凝血因子V具有抑制活性的单克隆IgG4(λ)。利用蛋白质电泳、免疫电泳和等电聚焦中定义迁移受限的单克隆免疫球蛋白的标准,以及用类、亚类和轻链型抗血清进行中和,我们首次证明了一种可在血清或血浆中检测到的作为单克隆IgG4(λ)的因子V抑制剂。

相似文献

1
A monoclonal IgG4 (lambda) with factor V inhibitory activity.一种具有因子V抑制活性的单克隆IgG4(λ)
J Immunol. 1979 May;122(5):2119-21.
2
[A double monoclonal IgG1-kappa and IgG3-lambda with electrophoretically same mobility in a single patient].[一名患者体内具有相同电泳迁移率的双单克隆IgG1-κ和IgG3-λ]
Rinsho Byori. 1990 Nov;38(11):1306-10.
3
Immunochemical characterization of antibodies to factor VIII in hemophilic and nonhemophilic patients.
J Lab Clin Med. 1981 Jun;97(6):791-800.
4
Serologically defined V region subgroups of human lambda light chains.人类λ轻链的血清学定义V区亚群
J Immunol. 1987 Aug 1;139(3):824-30.
5
[A circulating inhibitor specific to factor V. Clinical, biological and therapeutic study (author's transl)].[一种特异性针对因子V的循环抑制剂。临床、生物学及治疗学研究(作者译)]
Nouv Presse Med. 1981 Apr 25;10(18):1483-7.
6
Site-directed in vitro immunization leads to a complete human monoclonal IgG4 lambda that binds specifically to the CDR2 region of CTLA-4 (CD152) without interfering the engagement of natural ligands.定点体外免疫产生一种完全人源单克隆IgG4λ,其特异性结合CTLA-4(CD152)的CDR2区域,而不干扰天然配体的结合。
BMC Biotechnol. 2007 Aug 23;7:51. doi: 10.1186/1472-6750-7-51.
7
[Determination of the subclasses of monoclonal human immunoglobulins G and of the light chain type with the aid of specific antisera].[借助特异性抗血清鉴定人单克隆免疫球蛋白G的亚类及轻链类型]
Zh Mikrobiol Epidemiol Immunobiol. 1978 Apr(4):67-73.
8
Immunocytochemical detection of kappa and lambda light chain V region subgroups in human B-cell malignancies.人B细胞恶性肿瘤中κ和λ轻链V区亚群的免疫细胞化学检测
Am J Pathol. 1990 Oct;137(4):855-62.
9
A biclonal origin of two monoclonal proteins, IgG3(kappa) and IgA1(lambda), from a single patient.来自一名患者的两种单克隆蛋白IgG3(κ)和IgA1(λ)的双克隆起源。
Immunology. 1979 Aug;37(4):863-8.
10
The characterization of human anti-IgG autoantibodies by liquid isoelectric focussing.通过液相等电聚焦法对人抗IgG自身抗体进行表征。
J Immunol. 1975 Jan;114(1 Pt 1):176-81.

引用本文的文献

1
A Case of Acquired Factor V Inhibitor During Bullous Pemphigoid Treatment.1例大疱性类天疱疮治疗期间获得性因子V抑制剂病例
Cureus. 2024 Sep 10;16(9):e69090. doi: 10.7759/cureus.69090. eCollection 2024 Sep.
2
Inhibition of thromboxane A2 synthesis in human platelets by coagulation factor Xa.凝血因子Xa对人血小板中血栓素A2合成的抑制作用。
Proc Natl Acad Sci U S A. 1983 Oct;80(19):6086-90. doi: 10.1073/pnas.80.19.6086.
3
Heterogeneity of human factor V deficiency. Evidence for the existence of antigen-positive variants.人凝血因子V缺乏的异质性。抗原阳性变体存在的证据。
J Clin Invest. 1983 Aug;72(2):493-503. doi: 10.1172/jci110997.
4
Biosynthesis of factor V in isolated guinea pig megakaryocytes.豚鼠分离巨核细胞中凝血因子V的生物合成
J Clin Invest. 1985 Feb;75(2):339-46. doi: 10.1172/JCI111706.
5
Isolation and study of an acquired inhibitor of human coagulation factor V.人凝血因子V获得性抑制剂的分离与研究
J Clin Invest. 1986 Feb;77(2):405-15. doi: 10.1172/JCI112318.
6
An endothelial cell-dependent pathway of coagulation.一种内皮细胞依赖性凝血途径。
Proc Natl Acad Sci U S A. 1985 Apr;82(8):2523-7. doi: 10.1073/pnas.82.8.2523.
7
Characterization of an acquired inhibitor to coagulation factor V. Antibody binding to the second C-type domain of factor V inhibits the binding of factor V to phosphatidylserine and neutralizes procoagulant activity.获得性凝血因子V抑制剂的特性。抗体与因子V的第二个C型结构域结合会抑制因子V与磷脂酰丝氨酸的结合并中和促凝血活性。
J Clin Invest. 1992 Dec;90(6):2340-7. doi: 10.1172/JCI116123.